Rituximab or cyclosporine in the treatment of membranous nephropathy
FC Fervenza, GB Appel, SJ Barbour… - … England Journal of …, 2019 - Mass Medical Soc
Background B-cell anomalies play a role in the pathogenesis of membranous nephropathy.
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
[PDF][PDF] Rituximab or cyclosporine in the treatment of membranous nephropathy
T Li - 2019 - digitalcommons.wustl.edu
BACKGROUND B-cell anomalies play a role in the pathogenesis of membranous
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
FC Fervenza, GB Appel, SJ Barbour, BH Rovin… - New England Journal …, 2019 - cir.nii.ac.jp
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
FC Fervenza, GB Appel, SJ Barbour, BH Rovin… - 2019 - pubmed.ncbi.nlm.nih.gov
Background B-cell anomalies play a role in the pathogenesis of membranous nephropathy.
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
FC Fervenza, GB Appel, SJ Barbour, BH Rovin… - 2019 - repository.arizona.edu
Background: B-cell anomalies play a role in the pathogenesis of membranous nephropathy.
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
Rituximab or cyclosporine in the treatment of membranous nephropathy
FC Fervenza, GB Appel, SJ Barbour… - New England Journal …, 2019 - profiles.wustl.edu
BACKGROUND B-cell anomalies play a role in the pathogenesis of membranous
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
[PDF][PDF] Rituximab or cyclosporine in the treatment of membranous nephropathy
T Li - N Engl J Med, 2019 - core.ac.uk
BACKGROUND B-cell anomalies play a role in the pathogenesis of membranous
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
FC Fervenza, GB Appel, SJ Barbour… - The New England …, 2019 - europepmc.org
Background B-cell anomalies play a role in the pathogenesis of membranous nephropathy.
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine …
Rituximab or cyclosporine in the treatment of membranous nephropathy
FC Fervenza, GB Appel… - New England …, 2019 - ohiostate.elsevierpure.com
BACKGROUND B-cell anomalies play a role in the pathogenesis of membranous
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
Rituximab or cyclosporine in the treatment of membranous nephropathy
FC Fervenza, GB Appel… - New England …, 2019 - mayoclinic.elsevierpure.com
BACKGROUND B-cell anomalies play a role in the pathogenesis of membranous
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …
nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with …